Mei Yang

Title: Mei Yang - Innovator in Cancer Treatment

Introduction

Mei Yang is a prominent inventor based in Hong Kong, CN. She has made significant contributions to the field of cancer treatment through her innovative research and patented technologies. Her work focuses on utilizing modified bacteria for therapeutic purposes, particularly in combating various types of cancer.

Latest Patents

Mei Yang holds a patent for a method involving modified bacteria and their uses for the treatment of cancer or tumors. This patent describes a method that employs modified facultative anaerobic bacteria, which are transformed into conditional obligate anaerobes. The modified bacteria are strictly hypoxia regulated and include an essential gene expressing cassette. The method can be used in conjunction with other treatments such as chemotherapy, radiation therapy, gene therapy, and surgery. The modified bacteria are designed to grow within solid tumors, such as breast cancer, liver cancer, or neuroblastoma, effectively retarding tumor growth while being rapidly eliminated from normal tissues.

Career Highlights

Mei Yang is affiliated with The University of Hong Kong, where she conducts her research and develops her innovative treatments. Her work has garnered attention for its potential to revolutionize cancer therapy and improve patient outcomes.

Collaborations

Mei Yang collaborates with esteemed colleagues, including Jian-Dong Huang and Bin Yu, to advance her research and explore new avenues in cancer treatment.

Conclusion

Mei Yang's contributions to cancer treatment through her patented methods highlight her role as a leading innovator in the field. Her work not only showcases the potential of modified bacteria in medical applications but also emphasizes the importance of collaboration in scientific research.